Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
Clinical trial NCT00074282 · COMPLETED
Trial details
- NCT number
- NCT00074282
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-14
- Primary completion
- 2017-12-09
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.